Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank14
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
-153.08%
↑ 96% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-3912.90%
Historical baseline
PeriodValueYoY Change
TTM-153.08%+36.5%
2024-240.92%+99.4%
2023-38734.99%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-